Endocrine Abstracts

Background and aims: Intermediate hyperglycemia has been established to increase cardiovascular disease (CVD) risk. The increased platelet activity is believed to play a central role in pathogenesis of CVD. Mean platelet volume (MPV) and urinary 11-dehydro-thromboxane B2 (11-dehydro-TxB2) level have been validated as a reliable and non-invasive marker for platelet activity. The objective was to evaluate the association between these markers and CVD risk b...